0000000000650786

AUTHOR

M. Vitaliti

showing 4 related works from this author

A Snapshot on MRSA Epidemiology in a Neonatal Intensive Care Unit Network, Palermo, Italy

2016

Objectives. We performed a one-year prospective surveillance study on MRSA colonization within the five NICUs of the metropolitan area of Palermo, Italy. The purpose of the study was to assess epidemiology of MRSA in NICU from a network perspective. Methods. Transfer of patients between NICUs during 2014 was traced based on the annual hospital discharge records. In the period February 2014 – January 2015, in the NICU B, at the University teaching hospital, nasal swabs from all infants were collected weekly, whereas in the other four NICUs (A, C, D, E) at four week-intervals of time. MRSA isolates were submitted to antibiotic susceptibility testing, SCCmec typing, PCR to detect lukS-PV and l…

0301 basic medicineMicrobiology (medical)medicine.medical_specialtyNeonatal intensive care unithealth care facilities manpower and services030106 microbiologylcsh:QR1-502MRSAMicrobiologylcsh:Microbiology03 medical and health sciencesInternal medicineEpidemiologyMedicineInfection controlnetwork approachOriginal ResearchNICuActive surveillance; Molecular typing; MRSA; Network approach; NICu; Microbiology; Microbiology (medical)business.industryMRSA colonizationactive surveillancemolecular typingSequence typesVariable number tandem repeat030104 developmental biologyMultilocus sequence typingUniversity teachingbusinessFrontiers in Microbiology
researchProduct

MECASERMIN TREATMENT OF A CHILD WITH CONGENITAL HYPERINSULINISM LINKED TO INS-R MUTATION

2017

Objectives: Mecasermin is recombinant human insulin-like growth factor 1 (IGF1) which is approved for the treatment of short stature in children with documented primary IGF1 deficiency. Leprechaunism, also known as Donohue syndrome, is a severe disease, secondary to a severe congenital insulin resistance, with prenatal and neonatal growth retardation, typical dysmorphic features, glycaemic dysregulation characterized by hyperinsulinemia and hyperandrogenism. These patients have a poor prognosis with death in the first year of life. Methods: We describe the case of a 3.5 years child, born at 35,4 weeks, with severe fetal growth restriction (weight 1149 gr; length: 38 cm; cranial circumferenc…

Mecasermin IGF1Leprechaunism Donohue syndrome
researchProduct

Arteria ombelicale unica (AOU): un marker di anomalie congenite

2005

researchProduct

Terapia con Mecasermina in un bambino con iperinsulinismo congenito da mutazione INS-R

2017

Settore MED/38 - Pediatria Generale E SpecialisticaMecasermina iperinsulinismo congenito mutazione INS-R
researchProduct